FDA Warning Letter — Pure Indulgence Aesthetics

Case 723267 — FEI 3041017461

The FDA took a Warning Letter action against Pure Indulgence Aesthetics on April 1, 2026 (Southlake, TX). The action was issued by CDER and concerns drugs products.

Action Details

Facility
Pure Indulgence Aesthetics
Date
April 1, 2026
Fiscal Year
2026
Product Type
Drugs
Center
CDER
Location
Southlake, TX (United States)